News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Generex Biotechnology Corporation (GNBT) and SciGen Ltd (SIE.AX) Enter Into Distribution Agreement for Generex Oral-lyn in China


4/1/2008 11:35:17 AM

WORCESTER, Mass., April 1, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and SciGen, Ltd. (ASX:SIE) (www.scigenltd.com) announced today that the parties have entered into a product licensing and distribution agreement under which SciGen will procure governmental approvals for the importation, marketing, distribution, and sale of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, in the People's Republic of China, Hong Kong, and the following additional countries: Indonesia, South Korea, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES